Vivus’ Qnexa: Better for Diabetes, or Better for Weight Loss? (VVUS)

Vivus’ Qnexa: Better for Diabetes, or Better for Weight Loss? (VVUS) June 10, 2008 · Filed Under Diabetes · Comments Off Vivus Inc. (NASDAQ: VVUS) issued its awaited results on its mid-stage trial of its experimental drug Qnexa, showing that it lowered blood sugar levels and led to weight loss in patients with Type II diabetes. The results are from its 28-week trial involving 206 subjects, and Vivus said that patients on Qnexa achieved a 1.2% reduction in the key blood sugar measurement hem